Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × OTHER_GOV × Goserelin × Clear all

Phase

Phase 3 1 Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 31 INDUSTRY 22 NETWORK 19 NIH 7 OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasm Metastasis 1 Breast Neoplasms 1

Interventions

Radiotherapy 9 Carboplatin 7 Cisplatin 6 Capecitabine 6 Neoadjuvant Therapy 5 Gemcitabine 5 Fluorouracil 5 Docetaxel 5 Paclitaxel 4 Cyclophosphamide 4 Trastuzumab 3 Tamoxifen 3 Oxaliplatin 3 Hydralazine 3 Etoposide 3 Drug Therapy 3 pertuzumab 2 pegylated granulocyte colony-stimulating factor 2 palbociclib 2 Valproic Acid 2 Tranexamic Acid 2 Temozolomide 2 TP protocol 2 Surgical Procedures, Operative 2 Saline Solution 2 Radiotherapy, Adjuvant 2 Radiation 2 Proton Pump Inhibitors 2 Pemetrexed 2 Nivolumab 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03423199 2024-03-22

PATHWAY

National Cancer Center, Japan

Phase 3 Active not recruiting

Breast Neoplasms, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡